Scientists in the US have developed a new test for Parkinson’s disease, which has the potential to revolutionize the way that the illness is diagnosed and treated. Parkinson’s is characterized by the build-up of a protein called alpha-synuclein in the brain. The new test, which accurately measures the levels of this protein, was tried out on more than 1,000 participants, including those who had already been diagnosed with Parkinson’s disease, and those who were considered to be at risk of the disease. Experts hope that the development of such a test could lead to earlier diagnosis, more tailored treatment for patients and a search for a cure.
Breakthrough Parkinson’s Test Developed by US Researchers
US researchers have developed a breakthrough test for Parkinson’s disease. The technique was tested on over 1,000 participants, including those with a diagnosis of Parkinson’s disease, as well as “at-risk” individuals with gene variants linked to the condition. The test accurately measured levels of a protein called alpha-synuclein, which can indicate the presence of Parkinson’s. The development of such a test could lead to earlier diagnosis, more targeted treatments, and a search for a cure.
Latest from Blog
Manu Chopra, CEO of Karya Inc., emphasized the importance of utilizing artificial intelligence (AI) to reduce
Italy has decided to withdraw from China's Belt and Road Initiative, becoming the only G7 nation
Zerodha's top executives collectively received a remuneration of about ₹200 crore in the financial year 2022-23,
New research suggests that radiotherapy may not be necessary for many patients with ductal carcinoma in
The US Space Force's X-37B space plane is gearing up for its seventh mission, after landing
